90 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
the Restricted Period, then the Executive will have the duty and responsibility to promptly notify the Company of such relationship and cooperate in any
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts
8-K
EX-10.2
4xbph7 lzc
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.1
rwcw1 445fw8s9648e
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.1
lxpjp5 fv2
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
424B3
68ogdwou9xzcjn62
19 Oct 22
Prospectus supplement
6:10am
8-K
EX-10.1
0b1o6bnatozi705iv
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
j0pxtzrnkhoe 78fxlq
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
8-K
EX-10.1
u3ke 6je3mmfawj5
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
u5mss 917mhz7byk
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
gd325sv uj0pgf8omf28
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
7as7dc1wfqvg948923p
25 Apr 22
Prospectus supplement
5:02pm